Pharmasset announced April 03, 2007 that presentations of

preclinical studies of Clevudine for the treatment of hepatitis B

(HBV) will be made during the 42nd Annual Meeting of the

European Association for the Study of the Liver (EASL) being held

in Barcelona, Spain from April 11-15, 2007.

Clevudine-EASL2007-PHOSPHORYLATION-ABSTRACT.pdf